SI
IDXX icon

Stephens Inc’s Idexx Laboratories IDXX Stock Holding History

Stephens Inc’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85M Sell
3,295
-141
-4% -$90.4K 0.02% 484
2025
Q4 		$2.32M Buy
3,436
+149
+5% +$101K 0.03% 447
2025
Q3 		$2.1M Sell
3,287
-53
-2% -$32.2K 0.03% 476
2025
Q2 		$1.79M Buy
3,340
+1,608
+93% +$769K 0.02% 494
2025
Q1 		$727K Sell
1,732
-222
-11% -$96.4K 0.01% 691
2024
Q4 		$808K Sell
1,954
-443
-18% -$194K 0.01% 662
2024
Q3 		$1.21M Sell
2,397
-111
-4% -$53.9K 0.02% 559
2024
Q2 		$1.22M Buy
2,508
+894
+55% +$449K 0.02% 533
2024
Q1 		$871K Hold
1,614
– – 0.01% 622
2023
Q4 		$896K Sell
1,614
-344
-18% -$161K 0.02% 561
2023
Q3 		$856K Sell
1,958
-14
-0.7% -$6.98K 0.02% 556
2023
Q2 		$990K Buy
1,972
+2
+0.1% +$958 0.02% 556
2023
Q1 		$985K Buy
1,970
+268
+16% +$128K 0.02% 537
2022
Q4 		$694K Sell
1,702
-111
-6% -$43.1K 0.01% 597
2022
Q3 		$591K Buy
1,813
+190
+12% +$69.8K 0.01% 648
2022
Q2 		$569K Sell
1,623
-759
-32% -$310K 0.01% 686
2022
Q1 		$1.3M Sell
2,382
-184
-7% -$96.8K 0.02% 522
2021
Q4 		$1.69M Sell
2,566
-76
-3% -$47.7K 0.03% 484
2021
Q3 		$1.64M Sell
2,642
-697
-21% -$468K 0.03% 507
2021
Q2 		$2.11M Buy
3,339
+106
+3% +$58.5K 0.03% 468
2021
Q1 		$1.58M Sell
3,233
-125
-4% -$62.6K 0.03% 499
2020
Q4 		$1.68M Sell
3,358
-560
-14% -$251K 0.03% 461
2020
Q3 		$1.54M Buy
3,918
+366
+10% +$135K 0.03% 435
2020
Q2 		$1.17M Sell
3,552
-58
-2% -$16.8K 0.03% 480
2020
Q1 		$874K Buy
3,610
+526
+17% +$137K 0.02% 504
2019
Q4 		$805K Sell
3,084
-2,774
-47% -$731K 0.02% 606
2019
Q3 		$1.59M Buy
5,858
+59
+1% +$16.4K 0.04% 450
2019
Q2 		$1.6M Sell
5,799
-376
-6% -$92.6K 0.04% 453
2019
Q1 		$1.38M Buy
6,175
+208
+3% +$42.9K 0.03% 491
2018
Q4 		$1.11M Buy
5,967
+362
+6% +$74.2K 0.03% 501
2018
Q3 		$1.4M Buy
+5,605
New +$1.36M 0.03% 484
2017
Q3 		– Sell
-6,097
Closed -$984K – 780
2017
Q2 		$984K Sell
6,097
-637
-9% -$103K 0.03% 438
2017
Q1 		$1.04M Sell
6,734
-3,526
-34% -$486K 0.04% 416
2016
Q4 		$1.2M Sell
10,260
-452
-4% -$51.6K 0.05% 349
2016
Q3 		$1.21M Sell
10,712
-2,412
-18% -$254K 0.05% 336
2016
Q2 		$1.22M Sell
13,124
-2,596
-17% -$223K 0.05% 320
2016
Q1 		$1.23M Sell
15,720
-980
-6% -$70.6K 0.06% 307
2015
Q4 		$1.22M Sell
16,700
-208
-1% -$14.8K 0.06% 305
2015
Q3 		$1.25M Sell
16,908
-934
-5% -$66.9K 0.07% 298
2015
Q2 		$1.14M Buy
17,842
+3,950
+28% +$273K 0.05% 341
2015
Q1 		$1.07M Buy
13,892
+7,028
+102% +$547K 0.05% 342
2014
Q4 		$509K Buy
6,864
+962
+16% +$67.5K 0.02% 497
2014
Q3 		$348K Buy
5,902
+144
+3% +$9.1K 0.02% 574
2014
Q2 		$385K Sell
5,758
-1,244
-18% -$79.1K 0.02% 568
2014
Q1 		$425K Sell
7,002
-128
-2% -$7.63K 0.02% 503
2013
Q4 		$379K Sell
7,130
-260
-4% -$13.7K 0.02% 582
2013
Q3 		$368K Buy
7,390
+4,110
+125% +$198K 0.02% 543
2013
Q2 		$147K Buy
+3,280
New +$143K 0.01% 670

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stephens Inc's IDXX Position: Q1 2026 in Review

Stephens Inc reduced its Idexx Laboratories (IDXX) stake by 4.1% in Q1 2026, selling an estimated $90.4K and leaving 3,295 shares worth $1.85M. The position accounts for 0.02% of the portfolio, ranked #484.

Stephens Inc first reported a position in IDXX in Q2 2013 and has held it in 48 quarters since. The position peaked at $2.32M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Stephens Inc held 3,295 shares of Idexx Laboratories worth $1.85M as of Q1 2026.
  • Stephens Inc sold 141 Idexx Laboratories shares in Q1 2026, an estimated $90.4K.
  • Idexx Laboratories made up 0.02% of Stephens Inc's portfolio in Q1 2026, its #484 holding.
  • Stephens Inc first reported a position in Idexx Laboratories in Q2 2013 and has held it in 48 quarters since.
  • Stephens Inc's Idexx Laboratories position peaked at $2.32M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Stephens Inc's 13F filing for Q1 2026, filed 28 Apr 2026.